Wave Life Sciences sets Aug. 7 completion for Delaware redomiciliation
WVE•Delaware redomiciliation expected to complete Aug. 7
Wave Life Sciences set Aug. 7, 2026 as the expected completion date for its redomiciliation to the US.
The corporate reorganization shifts the group’s parent company from Singapore to a Delaware corporation.
The Singapore High Court approved the scheme of arrangement on July 14, 2026.
The move is expected to take effect after the close of trading on Aug. 7, 2026.
Wave plans to file a series of SEC forms after market close on the effective date.
